Noopept
Research Reliability -
A fast-acting, peptide-derived nootropic reported to support memory and focus at microgram-level doses.
Appetite
Mood
Sleep
Noopept
Description
Noopept is structurally related to the racetam family but is active at roughly 1,000 times lower doses than piracetam, suggesting a distinct or amplified mechanism — proposed pathways include increased BDNF and NGF expression alongside AMPA and NMDA receptor modulation. It has a notably fast onset, often reported within 15–30 minutes, which separates it from many nootropics that require weeks of loading. It is sold in Russia as an approved pharmaceutical for cognitive impairment but remains an unregulated research chemical in most Western markets, so sourcing purity and dosing accuracy falls entirely on the buyer.
Effects
First dose
subtle clarity within 15–30 minutes
Same day
best for focused cognitive work
Weeks
cumulative effects reported with cycled use
How it Feels
A short, clean lift in mental clarity and verbal flow within half an hour for many, more subtle than a stimulant. Some pair it with a choline source to avoid headaches. It is potent by weight, so precise low dosing matters and cycling is wise.
Usage
Commonly Referenced Starting Amount
Reference only — no consumer dose
Commonly Referenced Amount
In the United States this is an unapproved new drug and cannot lawfully be sold as a dietary supplement. We're not going to publish a consumer dose for something outside that framework.
Referenced Upper Limit
Not applicable outside clinical or research supervision
Onset
15–30 minutes
Combinations
Pairs well with
Synergistic
Choline source (Alpha-GPC or CDP-Choline) — racetam-family compounds increase acetylcholine turnover and commonly cause headaches without adequate choline
L-Theanine — smooths out the stimulating edge some users report
Avoid combining
Contraindicated
General research note: some studies discuss factors that may influence how this nutrient is absorbed or used by the body. This is educational information only, not medical advice — consult a qualified healthcare provider for guidance specific to you.
Biomarkers to Track
Subjective
(Daily)
Mental clarity and focus (1–10)
Headache occurrence
Verbal recall and working memory
Objective
(Quarterly)
Cognitive testing battery (n-back, reaction time)
Self-tracked focus duration during work blocks
Generally well tolerated at low doses, though long-term human data is limited. Potent by weight.
Pregnant women and anyone wanting well-established long-term safety.
Dosing too high (it is potent) and skipping a choline source, which can bring headaches.
Preliminary (limited / small human data)
The available human clinical literature is predominantly Russian-language and of variable methodological quality by Western standards; independent replication is limited.
Ostrovskaya RU et al. (2008). Bulletin of Experimental Biology and Medicine. Preclinical/clinical review (noopept). PMID: 19240864.